Last summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. But new research from the University of Georgia suggests that patients and caregivers may not experience ...
Jan 23, 2024
0
11
Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study led by Dana-Farber Cancer Institute scientists shows. Based on ...
Jan 5, 2024
0
125
Patients with lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), often undergo progressive kidney damage, with approximately 20% of these patients advancing to end-stage renal disease.
Dec 13, 2023
0
0
Before the development and distribution of COVID-19 vaccines, monoclonal antibodies (mAbs) were considered one of the most effective and widely used therapies to reduce the risk of progression to severe COVID, especially ...
Dec 11, 2023
0
0
Scientists believe a buildup of the brain protein amyloid beta plays a key role in the death of neurons, which can lead to Alzheimer's disease. Although most people develop some amyloid beta brain proteins as they age, researchers ...
Dec 11, 2023
0
24
Scientists have developed an antibody treatment that shows promise in blocking the potentially deadly effects of fentanyl for nearly a month, raising hopes for a new tool to combat overdoses.
Dec 6, 2023
0
15
Researchers have discovered the novel mechanism that underlies a previously reported observation that infection by group A Streptococcus bacteria reduces the risk of later developing type 1 diabetes.
Dec 5, 2023
0
1
After the outbreak of the novel coronavirus in 2020, vaccines, antibodies (Abs), small molecule drugs, and other interventions needed to be researched, and such a rapid development is partly due to the accumulation of scientific ...
Nov 27, 2023
0
0
A Brock-led international research team has discovered an immunotherapy method that could potentially add years to healthy aging. The research, published in the journal EMBO Molecular Medicine, introduces an innovative method ...
Nov 21, 2023
0
164
Children are an underutilized source of potential antibody therapies to counteract the "ever-evolving" COVID-19 pandemic, according to researchers at Vanderbilt University Medical Center.
Nov 9, 2023
0
61
